184 related articles for article (PubMed ID: 20981680)
1. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
[No Abstract] [Full Text] [Related]
2. New treatment options have changed the survival of patients with follicular lymphoma.
Fisher RI; LeBlanc M; Press OW; Maloney DG; Unger JM; Miller TP
J Clin Oncol; 2005 Nov; 23(33):8447-52. PubMed ID: 16230674
[TBL] [Abstract][Full Text] [Related]
3. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
4. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
5. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
6. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
Messori A; Fadda V; Maratea D; Trippoli S
Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
9. What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
Kenkre VP; Kahl BS
Cancer J; 2012; 18(5):383-9. PubMed ID: 23006941
[TBL] [Abstract][Full Text] [Related]
10. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
11. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
[No Abstract] [Full Text] [Related]
12. Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.
de Mendonça GR; Brito AB; Rocha RM; Delamain MT; de Andrade Natal R; Soares FA; Colleoni GW; Souza CA; Vassallo J; Lima CS
Blood Cancer J; 2016 Aug; 6(8):e464. PubMed ID: 27564462
[No Abstract] [Full Text] [Related]
13. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
14. Does monocyte count have prognostic significance in cancer?
Tadmor T
Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
[No Abstract] [Full Text] [Related]
15. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
[TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
17. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
Tobinai K
Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
[No Abstract] [Full Text] [Related]
18. Impact of age on genetics and treatment efficacy in follicular lymphoma.
Alig S; Jurinovic V; Pastore A; Bararia D; Häbe S; Hellmuth JC; Kridel R; Gascoyne R; Schmidt C; Zöllner AK; Buske C; Dreyling M; Unterhalt M; Hiddemann W; Hoster E; Weigert O
Haematologica; 2018 Aug; 103(8):e364-e367. PubMed ID: 29545350
[No Abstract] [Full Text] [Related]
19. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
[No Abstract] [Full Text] [Related]
20. Ileal polyposis caused by follicular lymphoma.
Matsuura M; Nakase H; Mochizuki N
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):e30. PubMed ID: 17625984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
